Is MITO or HDV a better dividend investment in 2026?

MITO currently yields 625.00% with a 5% 5-year dividend growth rate. HDV yields 2.92% with 4.8% growth. The better choice depends on your goal: MITO offers higher current income.

What is the dividend yield difference between MITO and HDV?

MITO has a forward dividend yield of 625.00% ($2.00/share annually). HDV yields 2.92% ($3.96/share annually). The yield gap is 622.08 percentage points.

Home › Compare › MITO vs HDV

MITO vs HDV: Dividend Comparison 2026

MITO yields 625.00% · HDV yields 2.92%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 MITO wins by $359450.78M in total portfolio value

INVESTMENT

TIME HORIZON10 years

MITO

● Live price

625.00%

Share price

$0.32

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$359450.81M

Annual income

$273,399,800,572.91

Full MITO calculator →

HDV

iShares Core High Dividend ETF

● Live price

2.92%

Share price

$135.39

Annual div

$3.96

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$24.3K

Annual income

$352.73

Full HDV calculator →

Portfolio growth — MITO vs HDV

📍 MITO pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	MITO	HDV
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, MITO + HDV cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

MITO pays

HDV pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MITO

Annual income on $10K today (after 15% tax)

$53,125.00/yr

After 10yr DRIP, annual income (after tax)

$232,389,830,486.97/yr

HDV

Annual income on $10K today (after 15% tax)

$248.52/yr

After 10yr DRIP, annual income (after tax)

$299.82/yr

At 15% tax rate, MITO beats the other by $232,389,830,187.15/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MITO + HDV for your $10,000?

MITO: 50%HDV: 50%

100% HDV50/50100% MITO

Portfolio after 10yr

$179725.42M

Annual income

$136,699,900,462.81/yr

Blended yield

76.06%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on MITO right now

MITO

Analyst Ratings

Buy

Consensus: Buy

HDV

No analyst data

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MITO buys

HDV buys

No recent congressional trades found for MITO or HDV in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricMITOHDV

Forward yield	625.00% ✓	2.92%
Annual dividend / share	$2.00	$3.96 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$359450.81M ✓	$24.3K
Annual income after 10y	$273,399,800,572.91 ✓	$352.73
Total dividends collected	$352328.39M ✓	$3.2K
Payment frequency	quarterly	quarterly
Sector	Stock	ETF

Year-by-year: MITO vs HDV ($10,000, DRIP)

Year	MITO Portfolio	MITO Income/yr	HDV Portfolio	HDV Income/yr	Gap
1← crossover	$73,200	$62,500.00	$11,002	$292.38	+$62.2K → MITO
2	$505,894	$427,570.09	$12,084	$300.36	+$493.8K → MITO
3	$3,302,979	$2,761,671.84	$13,250	$308.02	+$3.29M → MITO
4	$20,385,527	$16,851,339.68	$14,506	$315.35	+$20.37M → MITO
5	$119,012,643	$97,200,129.44	$15,858	$322.35	+$119.00M → MITO
6	$657,683,338	$530,339,810.29	$17,313	$329.04	+$657.67M → MITO
7	$3,442,734,786	$2,739,013,613.82	$18,878	$335.42	+$3442.72M → MITO
8	$17,083,489,966	$13,399,763,745.21	$20,560	$341.49	+$17083.47M → MITO
9	$80,421,501,126	$62,142,166,862.30	$22,367	$347.25	+$80421.48M → MITO
10	$359,450,806,778	$273,399,800,572.91	$24,307	$352.73	+$359450.78M → MITO

MITO vs HDV: Complete Analysis 2026

MITO — Stock

Stealth BioTherapeutics Corp, a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of therapies for diseases involving mitochondrial dysfunction. Its lead product candidate is Elamipretide that is in phase 3 clinical trial to treat barth syndrome, phase 2/3 clinical trial for the treatment of duchenne cardiomyopathy, phase 2a clinical trial to treat friedreich's ataxia, phase 2 clinical trial for the treatment of dry age-related macular degeneration, phase 2 clinical trial to treat leber's hereditary optic neuropathy, and phase 3 clinical trial for the treatment of replisome myopathies. The company's product candidates also include SBT-20 to treat complications of diabetes, renal diseases, ocular diseases, neurodegenerative, Parkinson's, Alzheimer's, Huntington's, and ALS diseases; SBT-550 for rare neurological indications; and SBT-272, a peptidomimetic that targets the mitochondria and stabilizing mitochondrial function under conditions of oxidative stress, as well as SBT 550. Stealth BioTherapeutics Corp was incorporated in 2006 and is based in George Town, the Cayman Islands.

Full MITO Calculator →

HDV — ETF

The iShares Core High Dividend ETF seeks to track the investment results of an index composed of relatively high dividend paying U.S. equities.

Full HDV Calculator →

📬

Get this MITO vs HDV comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MITO vs SCHD MITO vs JEPI MITO vs O MITO vs KO MITO vs MAIN MITO vs VYM MITO vs DVY MITO vs SPHD

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.